ETF Financing Ranking | Yinhua CSI Innovative Drugs Industry ETF (159992) had a net financing buy-in of CNY 30.35 million, ranked top among comparable funds-20260416

Apr 16, 2026, Yinhua CSI Innovative Drugs Industry ETF (159992.SZ) decreased by 0.34%, had a turnover of CNY 792.06 million. Obtained financing buy-in of CNY 97.37 million, and financing repayment of CNY 67.02 million, with a net financing buy-in of CNY 30.35 million, ranked top among comparable funds. (Data source: Wind)

Over a longer period, had leveraged funds with accelerated inflow over the last 3 days, with a total inflow of CNY 57.07 million, ranked first among comparable funds. (Data source: Wind)

Yinhua CSI Innovative Drugs Industry ETF (159992.SZ), off-exchange connection (A type: 012781; C type: 012782).

NewTimeSpace Disclaimer:All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.